Remdesivir in a pregnant patient with COVID-19 pneumonia
Ranadheer R. Dande, Anum Qureshi, Kia Persaud, Chahat Puri, Sajida Zulfiqar, Shankar Awasthi
Abstract
Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.
Topics & Concepts
MedicinePneumoniaCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPopulationIntensive care medicineBetacoronavirusVirologyInternal medicineInfectious disease (medical specialty)Environmental healthOutbreakDiseaseCOVID-19 Impact on ReproductionPregnancy and Medication ImpactMaternal Mental Health During Pregnancy and Postpartum